Sasin Payakachat
Role not yet determined Is this you? Add your title
Also affiliated: Washington University in St. Louis (2020)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Sasin Payakachat's research focuses on the bioactivation pathways of non-steroidal anti-inflammatory drugs (NSAIDs), specifically those containing the diphenylamine structure. Her work investigates how structural variations within these drugs influence their interaction with metabolic processes, particularly in the liver. Payakachat has published research examining the risks associated with halogenation in diphenylamine NSAIDs and has identified specific pathways through which these compounds can be bioactivated. Her work utilizes analytical techniques such as liquid chromatography and mass spectrometry to characterize these metabolic processes. Collaborators on this research include Grover Miller, Gunnar Boysen, and Benjamin Mark Schleiff from the University of Arkansas for Medical Sciences. Payakachat has a h-index of 2 with 3 total publications and 20 citations.
Metrics
- h-index: 2
- Publications: 3
- Citations: 20
Selected Publications
-
Structural Variations among Marketed Diphenylamine NSAIDs Determine Preference and Efficiency for Four Possible Bioactivation Pathways (2021)
-
Impacts of diphenylamine NSAID halogenation on bioactivation risks (2021)
-
Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics (2020)
Collaboration Network
Top Collaborators
- Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics
- Impacts of diphenylamine NSAID halogenation on bioactivation risks
- Structural Variations among Marketed Diphenylamine NSAIDs Determine Preference and Efficiency for Four Possible Bioactivation Pathways
- Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics
- Impacts of diphenylamine NSAID halogenation on bioactivation risks
- Structural Variations among Marketed Diphenylamine NSAIDs Determine Preference and Efficiency for Four Possible Bioactivation Pathways
- Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics
- Impacts of diphenylamine NSAID halogenation on bioactivation risks
- Structural Variations among Marketed Diphenylamine NSAIDs Determine Preference and Efficiency for Four Possible Bioactivation Pathways
- Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics
- Impacts of diphenylamine NSAID halogenation on bioactivation risks
- Structural Variations among Marketed Diphenylamine NSAIDs Determine Preference and Efficiency for Four Possible Bioactivation Pathways
- Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics
- Impacts of diphenylamine NSAID halogenation on bioactivation risks
- Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics
- Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics
- Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics
Similar Researchers
Based on overlapping research topics